A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

Clinical trial NCT06363760 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06363760
Sponsor: Editas Medicine, Inc.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Sickle Cell Disease Transfusion-dependent Beta-Thalassemia Hemoglobinopathies

Start date: 2024-06-17
Primary completion: 2040-08-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.